OTGR gets tough on GM field trials
Wednesday, 05 June, 2002
The Office of the Gene Technology Regulator (OGTR) has moved to tighten procedures for post-harvest monitoring and strengthen the management of GM field trials performed under the new regulatory system.
The "tough new conditions" will be applied to the first licence applications for field trials of GM canola since the new legislation went into effect.
The OGTR has called for public comment on the applications as part of its evaluation.
The applications have been made by Aventis CropScience for its InVigor canola, and by Monsanto for Roundup Ready canola. Both have been extensively trialled around Australia previously and the two companies have recently indicated intent to submit applications for commercial release in the near future.
The new procedures include an additional year of monitoring for field trial sites, and strengthened independent monitoring from the OGTR and possibly other bodies, including representatives from state governments. Extra research requirements on gene flow will also be required.
In addition, companies will be expected to fully comply with licence conditions.
"Following consultation with the expert groups and authorities prescribed in the Gene Technology Act 2000, I have prepared risk assessment and risk management plans for each of the applications which include the tougher post harvest monitoring conditions along with additional research requirements to confirm effectiveness of licence conditions in limiting gene flow," said the Commonwealth Gene Technology Regulator Dr Sue Meek in a statement.
Naomi Stevens, public affairs manager for Aventis, indicated that the changes were not substantially different from previous licences.
"Its essentially the same trial program we have been doing since 1996, but there will be more information flow to the government," she said.
"The system of administration has got tighter."
Stevens added that the new conditions would not have any bearing on Aventis CropScience's plans to file for commercial approval, as these field trials were part of an ongoing development of the GM canola variety for Australian conditions.
The OGTR has called for public comments on the licence applications and has extended the public consultation period until July 12th 2002.
"I am very conscious of the interest in the community about GM canola trials and I am extremely keen to receive feedback on the risk assessment and risk management plans and would also welcome views on additional issues which may be raised by possible future applications for the commercial release of GM canola," said Meek.
Plug-and-play test evaluates T cell immunotherapy effectiveness
The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight...
Common heart medicine may be causing depression
Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping...
CRISPR molecular scissors can introduce genetic defects
CRISPR molecular scissors have the potential to revolutionise the treatment of genetic diseases,...